64466-53-1

Upstream product

• 110-86-1 pyridine 
• 2632-13-5 2-Bromo-4'-methoxyacetophenone 
• 64467-11-4 (2-ethyl-indolizin-3-yl)-[4-(toluene-4-sulfonyloxy)-phenyl]-methanone 

Downstream Products

• 64467-91-0 2-ethyl-3-[4-(3-bromo-propyl)-oxy-benzoyl]-indolizine 
• 62228-20-0 butoprozine 
• 79283-14-0 (1-Bromo-2-ethyl-indolizin-3-yl)-[3,5-dibromo-4-(3-dibutylamino-propoxy)-phenyl]-methanone; compound with oxalic acid 
• 79285-53-3 (1-Bromo-2-ethyl-indolizin-3-yl)-[4-(3-dibutylamino-propoxy)-phenyl]-methanone; compound with oxalic acid 
• 79285-59-9 (1-Chloro-2-ethyl-indolizin-3-yl)-[4-(3-dipropylamino-propoxy)-phenyl]-methanone; compound with oxalic acid 
• 77833-05-7 1-bromo-2-ethyl-3-(3,5-dibromo-4-hydroxy-benzoyl)-indolizine 
• 77832-52-1 1-bromo-2-ethyl-3-(4-hydroxy-benzoyl)-indolizine 
• 77832-65-6 1-chloro-2-ethyl-3-(4-hydroxy-benzoyl)-indolizine 

Relevant academic research and scientific papers

Preparation method of antiarrhythmic drug butoprozine

The invention discloses a preparation method of an antiarrhythmic drug butoprozine. The preparation method comprises the following steps: (1) synthesizing a compound II from pyridine, alpha-bromo-p-methoxyacetophenone and methyl 2-pentenoate; 2) carrying

Indolizine derivatives, pharmaceutical compositions and methods containing same

Novel indolizine derivatives of the general formula: STR1 and pharmaceutically acceptable acid addition salts thereof, wherein R represents a branched- or straight-chain alkyl radical having from 1 to 5 carbon atoms, a phenyl radical, a mono-fluoro-, mono